Wedbush Downgrades Cerulean Pharma (CERU) to Neutral
Tweet
Share
E-mailGet Alerts CERU Hot Sheet
Price: $0.66 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Wedbush earlier downgraded Cerulean Pharma (NASDAQ: CERU) from Outperform to Neutral with a price target of $1.00 (from $9.00).
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $2.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
